Rilotumumab (Anti-HGF / SF)
Rilotumumab (Anti-HGF / SF) is a monoclonal antibody that inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research. MW: 145.5 KD.
| Trivial name | AMG 102 |
| Catalog Number | A2469 |
| CAS# | 872514-65-3 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/rilotumumab-anti-hgf-sf.html |